Tailored environments for directed mesenchymal stromal cell proliferation and differentiation using decellularized extracellular matrices in conjunction with substrate modulus.

acellular matrix cell-secreted matrix ex vivo expansion mechanobiology stem cell differentiation stem cell expansion

Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
22 Aug 2024
Historique:
received: 10 11 2023
revised: 04 08 2024
accepted: 16 08 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 24 8 2024
Statut: aheadofprint

Résumé

Decellularised extracellular matrix (dECM) produced by mesenchymal stromal cells (MSCs) is a promising biomaterial for improving the ex vivo expansion of MSCs. The dECMs are often deposited on high modulus surfaces such as tissue culture plastic or glass, and subsequent differentiation assays often bias towards osteogenesis. We tested the hypothesis that dECM deposited on substrates of varying modulus will produce cell culture environments that are tailored to promote the proliferation and/or lineage-specific differentiation of MSCs. dECM was produced on type I collagen-functionalised polyacrylamide hydrogels with discrete moduli (∼4, 10, and 40 kPa) or in a linear gradient of modulus that spans the same range, and the substrates were used as culture surfaces for MSCs. Fluorescence spectroscopy and mass spectrometry characterization revealed structural compositional changes in the dECM as a function of substrate modulus. Softer substrates (4 kPa) with dECM supported the largest number of MSCs after 7 days (∼1.6-fold increase compared to glass). Additionally, osteogenic differentiation was greatest on high modulus substrates (40 kPa and glass) with dECM. Nuclear translocation of YAP1 was observed on all surfaces with a modulus of 10 kPa or greater and may be a driver for the increased osteogenesis on the high modulus surfaces. These data demonstrate that dECM technology can be integrated with environmental parameters such as substrate modulus to improve/tailor MSC proliferation and differentiation during ex vivo culture. These results have potential impact in the improved expansion of MSCs for tailored therapeutic applications and in the development of advanced tissue engineering scaffolds. STATEMENT OF SIGNIFICANCE: Mesenchymal stromal cells (MSCs) are extensively used in tissue engineering and regenerative medicine due to their ability to proliferate, differentiate, and modulate the immune environment. Controlling MSC behavior is critical for advances in the field. Decellularized extracellular matrix (dECM) can maintain MSC properties in culture, increase their proliferation rate and capacity, and enhance their stimulated differentiation. Substrate stiffness is another key driver of cell function, and previous reports have primarily looked at dECM deposition and function on stiff substrates such as glass. Herein, we produce dECM on substrates of varying stiffness to create tailored environments that enhance desired MSC properties such as proliferation and differentiation. Additionally, we complete mechanistic studies including quantitative mass spec of the ECM to understand the biological function.

Identifiants

pubmed: 39181177
pii: S1742-7061(24)00467-7
doi: 10.1016/j.actbio.2024.08.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michael C Yang (MC)

Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC, Australia; Department of Maternal-Fetal Medicine Pregnancy Research Centre, Royal Women's Hospital, Parkville, VIC, Australia.

Ian L Chin (IL)

School of Human Sciences, University of Western Australia, Crawley, Western Australia, Australia.

Haoyun Fang (H)

Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC Australia.

Auriane Drack (A)

Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC Australia.

Shirin Nour (S)

Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC, Australia; Department of Chemical Engineering, Polymer Science Group, University of Melbourne, Parkville, VIC, Australia.

Yu Suk Choi (YS)

School of Human Sciences, University of Western Australia, Crawley, Western Australia, Australia.

Andrea J O'Connor (AJ)

Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC, Australia.

David W Greening (DW)

Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; Department of Cardiovascular Research, Translation, and Implementation, La Trobe University, Bundoora, VIC, Australia; Central Clinical School, Monash University, Clayton, VIC, Australia; Department of Cardiometabolic Health, University of Melbourne, Parkville, VIC Australia.

Bill Kalionis (B)

Department of Maternal-Fetal Medicine Pregnancy Research Centre, Royal Women's Hospital, Parkville, VIC, Australia; Department of Obstetrics, Gynaecology and Newborn Health, University of Melbourne, Parkville, VIC, Australia. Electronic address: bill.kalionis@thewomens.org.au.

Daniel E Heath (DE)

Department of Biomedical Engineering, Graeme Clark Institute, University of Melbourne, Parkville, VIC, Australia. Electronic address: daniel.heath@unimelb.edu.au.

Classifications MeSH